
Phase 1 randomized double-blind safety and immunogenicity trial of Plasmodium falciparum malaria merozoite surface protein FMP1 vaccine, adjuvanted with AS02A, in adults in western Kenya
José A. Stoute, Joash Gombe, Mark R. Withers, Joram Siangla, Denise McKinney, Melanie Onyango, James F. Cummings, Jessica Milman, Kathryn Tucker, Lorraine Soisson, V. Ann Stewart, Jeffrey A. Lyon, EveVolume:
25
Année:
2007
Langue:
english
DOI:
10.1016/j.vaccine.2005.11.037
Fichier:
PDF, 325 KB
english, 2007